In MDS, multi-hit TP53 disruption (in the subsets of multiple mutations, mutation plus 17p deletion, or mutation plus loss of heterozygosity) frequently presents with a higher rate of additional chromosomal abnormalities compared to monoallelic/single-hit mutation and significantly worse prognosis [115]. Here, TP53 is linked to myelodysplastic syndrome.